<http://webisa.webdatacommons.org/prov/175856105>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/100663584> .
<http://webisa.webdatacommons.org/100663584>	<http://www.w3.org/ns/prov#value>	"The sIL-1R of the present invention can be of any type, including Type I and Type II. The Type I sIL-1R is an 80 Kd glycoprotein that is present on T-lymphocytes, fibroblasts, and chondrocytes." .
<http://webisa.webdatacommons.org/100663584>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.fr> .
<http://webisa.webdatacommons.org/100663584>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .